SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Two top executives at Dyne Therapeutics, the CEO and Chief Medical…

Dyne Therapeutics, Inc. · CLUSTER filed Mar 4, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 4, 2026 at 19:00 ET

Two top executives at Dyne Therapeutics, the CEO and Chief Medical Officer, sold shares in a coordinated open-market transaction totaling approximately $54,200. The sales represent a routine divestiture with minimal dollar value relative to the company's $2.5B market cap.

  • CEO John Cox sold 2,732 shares for $40,706.80 in an open-market transaction.
  • Chief Medical Officer Douglas Kerr sold 904 shares for $13,469.60, also via open-market sale.
  • Total value of insider sales: $54,176.40 across two C-suite executives.
  • Sales occurred on the same day at $14.90 per share, within normal trading activity.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access